ABBOTT LABORATORIES Current Liabilities 2007-2026 | ABT
Beta
What is current liabilities?
Current liabilities are obligations expected to be settled within one year or the normal operating cycle of the business.
What is ABBOTT LABORATORIES's current current liabilities?
ABBOTT LABORATORIES (ABT) annual current liabilities for 2025 was $16.50B, a 16.52% increase from 2024. ABBOTT LABORATORIES current liabilities for the quarter ending March 31, 2026 was $18.38B.
What was ABBOTT LABORATORIES's current liabilities in 2024?
ABBOTT LABORATORIES annual current liabilities for 2024 was $14.16B, a 2.28% increase from 2023.
What was ABBOTT LABORATORIES's current liabilities in 2023?
ABBOTT LABORATORIES annual current liabilities for 2023 was $13.84B, a 10.64% decline from 2022.
What is ABBOTT LABORATORIES's 5-year current liabilities CAGR?
ABBOTT LABORATORIES current liabilities grew at a compound annual growth rate (CAGR) of 6.74% from FY2020 to FY2025, going from $11.91B to $16.50B over 5 years.
Current Liabilities History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+6.7%
FY2020
$11.91B
→
FY2025
$16.50B
07080910111213141516171819202122232425
5 years selected
Current Liabilities History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $16.50B | +16.5% | 10-K |
| FY2024 | $14.16B | +2.3% | 10-K |
| FY2023 | $13.84B | -10.6% | 10-K |
| FY2022 | $15.49B | +18.2% | 10-K |
| FY2021 | $13.11B | +10.1% | 10-K |
| FY2020 | $11.91B | +9.6% | 10-K |
| FY2019 | $10.86B | +20.5% | 10-K |
| FY2018 | $9.01B | +1.1% | 10-K |
| FY2017 | $8.91B | +33.8% | 10-K |
| FY2016 | $6.66B | -27.5% | 10-K |
| FY2015 | $9.19B | -12.2% | 10-K |
| FY2014 | $10.47B | +10.1% | 10-K |
| FY2013 | $9.51B | -28.4% | 10-K |
| FY2012 | $13.28B | -14.2% | 10-K |
| FY2011 | $15.48B | -10.3% | 10-K |
| FY2010 | $17.26B | +32.3% | 10-K |
| FY2009 | $13.05B | +12.6% | 10-K |
| FY2008 | $11.59B | +27.3% | 10-K |
| FY2007 | $9.10B | - | 10-K |
Company: ABBOTT LABORATORIESTicker: ABTSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →